Pharmaceutical Intermediates

Lesinurad/1440-61-5/CME

Lesinurad/1440-61-5/CME
  • Lesinurad/1440-61-5/CME
  • Lesinurad/1440-61-5/CME

Approx. Rs 100 / Gram


Lesinurad is an oral uric acid transporter 1 (URAT1) inhibitor indicated for the treatment of hyperuricemia associated with gout. It reduces serum uric acid concentration through the inhibition of URAT1, an enzyme responsible for reuptake of uric acid from the renal tubule, and OAT4, another uric acid transporter associated with diuretic-induced hyperuricemia.
Specification:
Intermediate: 2-chloromorpholinoehtan-1-one/CME
CAS No: 1440-61-5
API/End use: Lesinurad

Additional Information:

Mirabegron/29968-78-3/MRG2

Mirabegron/29968-78-3/MRG2

Approx. Rs 72 / Gram


Mirabegron is a pharmaceutical drug, indicated for the effective treatment of overactive bladder. It leads to muscle relaxation and an increase in bladder capacity by activating Ã23 adrenergic receptor present in the detrusor muscle of bladder. Recently, this drug has shown its efficacy in activating brown fat and increase in metabolism. Based on a small study, this drug is proved to exhibit the ability of increasing metabolic rate, basal heart rate and blood pressure that are major signs of cardiovascular stimulation.

Specifications :
IntermediateCAS NoAPI/End Use
2-Amino-4-thiazole acetic acid29679-71-9Mirabegron
2-(4-nitrophenyl)ethanamine hydrochloride29968-78-3Mirabegron
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl] benzeneacetamide521284-19-5Mirabegron
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride521284-21-9Mirabegron
(R)-2-(4-aminophenethylamino)-1-Phenylethanol HCL521284-22-0Mirabegron
[2-(4-Aminophenyl)ethyl]carbamic acid tert-butyl ester94838-59-2Mirabegron

Additional Information:

Racecadotril/5669-19-2/RAC2

Racecadotril/5669-19-2/RAC2

Approx. Rs 35 / Gram


Racecadotril Intermediates include 2-Benzyl acrylic acid with CAS No of 5669-19-2, Purity of NLT 98.00%, end usage as Racecadotril, CB Number of CB7272895, Molecular Formula of C10H10O2, Formula Weight of 162.19 and appearance as White Solid form. The other intermediate offered is Benzyl glycinate p-toluene sulfonate with CAS No of 1738-76-7, Purity of NLT 97.00% and end usage as Racecadotril. Its other properties include Formula of C9H11NO2.C7H8O3S, Molecular Weight of 337.39, Melting Point of 132-134 °C, Boiling Point of 245.5 °C at 760 mmHg, Flash Point of 110.3 °C and appearance as a white to off-white microcrystalline powder form.

Additional Information:

Sitagliptin Phosphate/764667-65-4/SITA2

Sitagliptin Phosphate/764667-65-4/SITA2

Approx. Rs 210 / Gram


Sitagliptin Phosphate

Sitagliptin Phosphate CAS No 762240-92-6 is a dipeptidyl peptidase-4 inhibitor. Januvia (Sitagliptin Phosphate) drug effectively works in type 2 diabetes by slowing the inactivation of incretin hormones. With scientific name 3-(tri fluoro methyl)-5, 6, 7, 8-tetra hydro--(1,2,4) Triazolo [4,3-a]-pyrazine HCl and molecular formula C16H15F6N5O•H3PO4•H2O, this is widely added to several medical formulations. With molecular weight of 523.32, this pharmaceutical intermediate comes in the form of a white to off-white, crystalline and non-hygroscopic powder. It is soluble in water, slightly soluble in methanol and insoluble in isopropanol.

Additional Information:

Solifenacin/1193-65-3/RCN2

Solifenacin/1193-65-3/RCN2

Approx. Rs 85 / Gram


Specifications :
IntermediateCAS NoAPI/End Use
3-Quinuclidinone hydrochloride1193-65-3Solifenacin

Additional Information:

Dabigatran Intermediate/212322-56-0/CBA3

Dabigatran Intermediate/212322-56-0/CBA3

Approx. Rs 80 / Gram


Dabigatran 

Belong to a special class of medicine called direct thrombin inhibitor; Dabigatran is widely used as an oral anticoagulant. It is also sometimes used as the alternative to wayfaring, due to excellent anticoagulant properties (blood thinner). It is preferred for various clinical indications as it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.

Specifications :
IntermediateCAS NoAPI/End Use
3-amino-4-methylamino-benzoic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)-amide212322-56-0Dabigatran







Additional Information:

Eliglustat/20989-17-7/ELG

Eliglustat/20989-17-7/ELG

Approx. Rs 80 / Gram


Specifications :
IntermediateCAS NoAPI/End Use



S(+)-2-Phenylglycinol20989-17-7Eliglustat


Additional Information:

Bendamustine/3543-72-4/Dam3

Bendamustine/3543-72-4/Dam3

Approx. Rs 200 / Gram


Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Specifications:Intermediate: Ethyl4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoateCAS No: 3543-72-4API/End use: Bendamustine

Additional Information:

Bendamustine/3543-73-5/DAM4

Bendamustine/3543-73-5/DAM4

Approx. Rs 220 / Gram


Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein. 

Specifications:
Intermediate: Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole-2-yl)butanoate
CAS No: 3543-73-5
API/End use: Bendamustine

Additional Information:

Camostat Mesylate/16060-65-4/GBA

Camostat Mesylate/16060-65-4/GBA

Approx. Rs 80 / Gram


Camostat is a serine protease inhibitor. Serine protease enzymes have a variety of functions in the body, and so camostat has a diverse range of uses. It is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis

Additional Information:

Camostat Mesylate/59721-16-3/CST

Camostat Mesylate/59721-16-3/CST

Approx. Rs 50 / Gram


Camostat is a serine protease inhibitor. Serine protease enzymes have a variety of functions in the body, and so camostat has a diverse range of uses. It is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis

Specifications:

Intermediate: 4-Hydroxy Benzeneacetic Acid 2-(Dimethylamino)-2-oxoethyl Ester

CAS No: 59721-16-3

API/End use: Camostat Mesylate


Additional Information:

Camostate Mesylate/42823-46-1/Gba Hcl

Camostate Mesylate/42823-46-1/Gba Hcl

Approx. Rs 70 / Gram


Camostat is a serine protease inhibitor. Serine protease enzymes have a variety of functions in the body, and so camostat has a diverse range of uses. It is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis

Specifications:Intermediate: 4- GUANIDINOBENZOIC ACID HCLCAS No: 42823-46-1API/End use: Camostat Mesylate

Additional Information:

Dabigatran/211915-06-9/DBG3

Dabigatran/211915-06-9/DBG3

Approx. Rs 305 / Gram


Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots.

Specifications:

Intermediate: Ethyl 3-(((2-(((4-(((( hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methy-lH-benzimidazole-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate/

CAS No: 211915-06-9API/End use: Dabigatran

Additional Information:

Dabigatran/211915-84-3/DBG1

Dabigatran/211915-84-3/DBG1

Approx. Rs 190 / Gram


Dabigatran 

 
Belong to a special class of medicine called direct thrombin inhibitor; Dabigatran is widely used as an oral anticoagulant. It is also sometimes used as the alternative to wayfaring, due to excellent anticoagulant properties (blood thinner). It is preferred for various clinical indications as it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy. 

Specifications:

Intermediate: Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate.

CAS No: 211915-84-3 API/End use: Dabigatran

Additional Information:

Dabigatran/429658-95-7/Dbg2

Dabigatran/429658-95-7/Dbg2

Approx. Rs 250 / Gram


Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots.

Specifications:

Intermediate: Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride.


Additional Information:

Dasatinib/302964-02-9/Dtb3

Dasatinib/302964-02-9/Dtb3

Approx. Rs 150 / Gram


Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Specifications:

Intermediate: 2-(N-BOC)-Aminothiazole-5-carboxylic acid


Additional Information:

Droxidopa/5447-02-9/DZB

Droxidopa/5447-02-9/DZB

Approx. Rs 35 / Gram


Droxidopa is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine. Unlike norepinephrine, droxidopa is capable of crossing the protective blood–brain barrier.

Specifications:

Intermediate: 3,4-Dibenzyloxybenzaldehyde

 CAS No: 5447-02-9

API/End use: Droxidopa



Additional Information:

Elagolix/102089-74-7 /RPG2

Elagolix/102089-74-7 /RPG2

Approx. Rs 160 / Gram


Elagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of pain associated with endometriosis in women. It is also under development for the treatment of uterine fibroids and heavy menstrual bleeding in women.

Specifications:

Intermediate: N-Boc-D-phenyl glycinol 

CAS No: 102089-74-7

API/End use: Elagolix


Additional Information:

Elvitegravir/161531-51-7/EVI-1

Elvitegravir/161531-51-7/EVI-1

Approx. Rs 120 / Gram


Elvitegravir is an integrase inhibitor used to treat HIV infection. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008.

Specifications:

Intermediate: 2, 4-Difluoro-5-Iodobenzoic acid

CAS No: 161531-51-7

API/End use: Elvitegravir


Additional Information:

Imatinib/152460-10-1/IMA5

Imatinib/152460-10-1/IMA5

Approx. Rs 100 / Gram


Imatinib, sold under the brand names Gleevec among others, is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia and acute lymphocytic leukemia that are Philadelphia chromosome-positive, certain types of gastrointestinal stromal tumour’s, hypereosinophilic syndrome, chronic eosinophilic leukemia, systemic mastocytosis, and myelodysplastic syndrome.

Specifications:

Intermediate: N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine

CAS No: 152460-10-1

API/End use: Imatinib


Additional Information:

Ivacaftor/13721-01-2/IVF3P

Ivacaftor/13721-01-2/IVF3P

Approx. Rs 280 / Gram


Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis.

Specifications:

Intermediate: 4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS No: 13721-01-2

API/End use: Ivacaftor


Additional Information:

Ivacaftor/52980-28-6/IVF2

Ivacaftor/52980-28-6/IVF2

Approx. Rs 250 / Gram


Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis.

Specifications:

Intermediate: Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate

CAS No: 52980-28-6

API/End use: Ivacaftor


Additional Information:

Ivacaftor/873055-58-4/TBP

Ivacaftor/873055-58-4/TBP

Approx. Rs 100 / Gram


Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis.

Specifications:

Intermediate: 5-Amino-2,4-ditert-butylphenol

CAS No: 873055-58-4

 

API/End use: Ivacaftor


Additional Information:

Mirabegron/223673-35-6/BOC MRG4

Mirabegron/223673-35-6/BOC MRG4

Approx. Rs 350 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: (R)-4-nitro phenethylamino-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate

CAS No: 223673-35-6

API/End use: Mirabegron


Additional Information:

Mirabegron/29676-71-9/ATA 2

Mirabegron/29676-71-9/ATA 2

Approx. Rs 42 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: 2-(2-Aminothiazol-4-yl)acetic acid

CAS No: 29676-71-9

 

API/End use: Mirabegron


Additional Information:

Mirabegron/391901-45-5/MRG-5 BASE

Mirabegron/391901-45-5/MRG-5 BASE

Approx. Rs 350 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol

CAS No: 391901-45-5

 

API/End use: Mirabegron


Additional Information:

Mirabegron/521284-21-9/MRG4

Mirabegron/521284-21-9/MRG4

Approx. Rs 300 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: (R)-2-(4-nitrophenethylamino)-1-phenylethanol  hydrochloride

CAS No: 521284-21-9

 

API/End use: Mirabegron


Additional Information:

Mirabegron/521284-22-0/MRG5

Mirabegron/521284-22-0/MRG5

Approx. Rs 380 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: (R)-2-(4-aminophenethylamino)-1-Phenylethanol HCL

CAS No: 521284-22-0

 

API/End use: Mirabegron


Additional Information:

Mirabegron/53266-94-7/ATA 1

Mirabegron/53266-94-7/ATA 1

Approx. Rs 38 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: Ethyl 2-(2-aminothiazol-4-yl)acetate

CAS No: 53266-94-7

API/End use: Mirabegron


Additional Information:

Mirabegron/66659-20-9/ATA 2 HCL

Mirabegron/66659-20-9/ATA 2 HCL

Approx. Rs 35 / Gram


Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to other antimuscarinic medication such as solifenacin or tolterodine. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.

Specifications:

Intermediate: 2-(2-Aminothiazol-4-yl)acetic acid hydrochloride

CAS No: 66659-20-9

 

API/End use: Mirabegron


Additional Information:

Oxatomide/62780-89-6/OXT2

Oxatomide/62780-89-6/OXT2

Approx. Rs 80 / Gram


Oxatomide, sold under the brand name Tinset among others, is a first-generation antihistamine of the diphenylmethylpiperazine family which is marketed in Europe, Japan, and a number of other countries. It was discovered at Janssen Pharmaceutica in 1975. Oxatomide lacks any anticholinergic effects.

Specifications:

Intermediate: 1-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one

CAS No: 62780-89-6

 

API/End use: Oxatomide


Additional Information:

Dabigatran Intermediate/42288-26-6/CBA4

Dabigatran Intermediate/42288-26-6/CBA4

Approx. Rs 45 / Gram


We have an offer of a highly effective range of active pharmaceutical ingredients, which are extensively used for making formulations. We follow GMP guidelines to formulate this range which are accepted across the Indian and overseas market. In order to meet the diverse requirements of our clients.

GENERIC NAMESpecificationTHERAPEUTIC USAGEStatus
Clopidogrel bi sulphateIP/USPCardiovascularCommercial
Quetiapine fumarateIP / USPAnti-psychoticUnder Scale - Up
Rosuvastatin CalciumIP/EPAnti-lipemicUnder development
Dabigatran Etexilate MesylateIn-houseAnti-CoagulantUnder development
EtodolacIP/USP/EPNSAIDCommercial
SparfloxacinInhouseAntibioticCommercial
Adenosine IPIPAnti - Arrhythmic AgentLab Scale
Ketorolac TromethamineIP/USP/EPNSAIDUnder Development

Additional Information:

Bendamustine/1313020-26-6/BEN5

Bendamustine/1313020-26-6/BEN5

Approx. Rs 280 / Gram


Bendamustine with CAS No 1313020-26-6 belongs to the family of drugs called alkylating agents. Recognized in the entire pharmaceutical industry with its scientific name 4-(5-amino-1-methyl-1H-benzimidazol-2-yl)-butyric acid isopropyl ester, it has molecular formula C16H21Cl2N3O2 and molecular weight 358.262 g/mol.

This pharmaceutical drug is nitrogen mustard, widely prescribed for the treatment of chronic lymphocytic leukemia and lymphomas. Comes in the form of a white, water soluble microcrystalline powder; this drug has excellent amphoteric properties. This effectively acts as an alkylating agent that causes intra-strand and inter-strand cross-links between DNA bases.

IntermediateCAS NoAPI/End Use
4-(5-amino-1-methyl-1H-benzimidazol-2-yl)-butyric acid isopropyl ester1313020-26-6Bendamustine
Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate3543-73-5Bendamustin HCL
Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl) butanoate3543-72-4Bendamustin HCL

Additional Information:

Dasatinib/302964-08-5/ATC4

Dasatinib/302964-08-5/ATC4

Approx. Rs 500 / Gram


Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Specifications:

Intermediate: N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide

CAS No: 302964-08-5
API/End use: Dasatinib

Additional Information:

Dasatinib/863127-76-8/ATC2

Dasatinib/863127-76-8/ATC2

Approx. Rs 250 / Gram


Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Specifications:

Intermediate: (E) -N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide

CAS No: 863127-76-8

API/End use: Dasatinib


Additional Information:

Dasatinib/302964-24-5/ATC3

Dasatinib/302964-24-5/ATC3

Approx. Rs 420 / Gram


Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Specifications:

Intermediate: 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide

CAS No: 302964-24-5
API/End use: Dasatinib

Additional Information:

Dasatinib/1780-26-3/PMD

Dasatinib/1780-26-3/PMD

Approx. Rs 85 / Gram


Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Specifications:

Intermediate: 4,6-dichloro-2-methylpyrimidine

CAS No: 1780-26-3

API/End use: Dasatinib


Additional Information:
X
Provide Us More Details
Purpose of Requirement:

Reselling End Use Raw Material

X

Looking for Pharmaceutical Intermediates ?

    country-ico

    We will contact you soon !

    G. Srikala

    (Marketing)

    A. R. Life Sciences Private Limited

    Gachibowli, Hyderabad, Telangana, India

    More Categories

    View All Categories »
    Send SMS
    Contact Us